Literature DB >> 2188338

Individualization of the cutoff value for serum squamous-cell carcinoma antigen using a sensitive enzyme immunoassay.

N Takeshima1, K Nakamura, O Takeda, H Morioka, H Tamura, N Takasugi, H Kato.   

Abstract

A sensitive enzyme immunoassay (IMx) for the squamous-cell carcinoma (SCC) antigen was used to evaluate low concentrations of this marker in the blood circulation. The assay can detect 0.05 ng/ml of serum SCC antigen, with intra- and interassay variabilities of 4.8 and 8.9%, respectively. Daily changes in serum SCC antigen were determined in healthy volunteers and in patients with cervical squamous-cell carcinoma after complete resection of the primary tumor, which revealed that, although the absolute values were variable from one case to another, the daily changes were relatively constant in each case, with a mean daily variation of 24.1 +/- 3.7% (mean +/- SE). The determination of the cutoff value for each individual patient may be effective for the early detection of an abnormal rise of circulating tumor marker, and will be useful in detecting small tumor foci during follow-up after treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2188338     DOI: 10.1159/000217651

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  2 in total

1.  Squamous cell carcinoma antigen suppresses radiation-induced cell death.

Authors:  A Murakami; Y Suminami; H Hirakawa; S Nawata; F Numa; H Kato
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

2.  Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.

Authors:  Y Suminami; S Nagashima; N L Vujanovic; K Hirabayashi; H Kato; T L Whiteside
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.